Human cytomegalovirus gene expression in long-term infected glioma stem cells

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Fiallos, Estefania ^a   Judkins, Jonathon ^a   Matlaf, Lisa ^a   Prichard, Mark ^b   Dittmer, Dirk ^c   Cobbs, Charles ^d,e   Soroceanu, Liliana ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d SWEDISH MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MEMBRANE PROTEIN; PROTEIN BMX; STAT3 PROTEIN; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BRAIN TISSUE; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CELL SPECIFICITY; CELL STEMNESS; CELL SURVIVAL; CELLULAR PARAMETERS; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE PRODUCT; GLIOBLASTOMA; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; INTRACELLULAR SIGNALING; NONHUMAN; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS STRAIN; BRAIN TUMOR; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFECTS; GENETICS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VIROLOGY; VIRUS CELL TRANSFORMATION;

HUMAN HERPESVIRUS 5;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GLIOMA; HUMANS; INTERLEUKIN-6; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 84920149197     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116178     Document Type: Article

References (43)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
3. Gilbert CA, Ross AH (2009) Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem 108: 1031-1038.
4. Chen J, Li Y, Yu TS, McKay RM, Burns DK, et al. (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488: 522-526.
5. Johnsen JI, Baryawno N, Soderberg-Naucler C (2011) Is human cytomegalovirus a target in cancer therapy? Oncotarget 2: 1329-1338.
6. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, et al. (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62: 3347-3350.
7. Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, et al. (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 10: 10-18.
8. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R (2008) Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116: 79-86.
9. Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF (2012) Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples. J Virol 86: 854-864.
10. Bhattacharjee B, Renzette N, Kowalik TF (2012) Genetic analysis of cytomegalovirus in malignant gliomas. J Virol 86: 6815-6824.
11. Dos Santos CJ, Stangherlin LM, Figueiredo EG, Correa C, Teixeira MJ, et al. (2013) High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients. J Med Virol.
12. Fonseca RF, Kawamura MT, Oliveira JA, Teixeira A, Alves G, et al. (2012) The prevalence of human cytomegalovirus DNA in gliomas of Brazilian patients. Mem Inst Oswaldo Cruz 107: 953-954.
13. Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C (2011) The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol 103: 231-238.
14. Bianchi E, Roncarati P, Hougrand O, Guerin-El Khourouj V, Boreux R, et al. (2014) Human cytomegalovirus and primary intracranial tumors: frequency of tumor infection and lack of correlation with systemic immune anti-viral responses. Neuropathol Appl Neurobiol.
15. Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, et al. (2012) Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol 14: 246-255.
16. Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol 87: 1763-1779.
17. Ryan KJ, Ray CG (2010) Chapter 7. Pathogenesis of Viral Infection. Sherris Medical Microbiology, 5e. New York, NY: The McGraw-Hill Companies.
18. Schmittgen TD, Lee EJ, Jiang J (2008) High-throughput real-time PCR. Methods Mol Biol 429: 89-98.
19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
20. Soroceanu L, Kharbanda S, Chen R, Soriano RH, Aldape K, et al. (2007) Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma. Proc Natl Acad Sci U S A 104: 3466-3471.
21. Hu Y, Smyth GK (2009) ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347: 70-78.
22. Matlaf LA, Harkins LE, Bezrookove V, Cobbs CS, Soroceanu L (2013) Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PLoS One 8: e68176.
23. Guryanova OA, Wu Q, Cheng L, Lathia JD, Huang Z, et al. (2011) Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 19: 498-511.
24. Duan YL, Ye HQ, Zavala AG, Yang CQ, Miao LF, et al. (2014) Maintenance of Large Numbers of Virus Genomes in Human Cytomegalovirus-Infected T98G Glioblastoma Cells. J Virol 88: 3861-3873.
25. Zhou M, Yu Q, Wechsler A, Ryckman BJ (2013) Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope. J Virol 87: 9680-9690.
26. Ryckman BJ, Chase MC, Johnson DC (2010) Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J Virol 84: 2597-2609.
27. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
28. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104: 10158-10163.
29. Ernst A, Hofmann S, Ahmadi R, Becker N, Korshunov A, et al. (2009) Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res 15: 6541-6550.
30. Belzile JP, Stark TJ, Yeo GW, Spector DH (2014) Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA. J Virol 88: 4021-4039.
31. Hargett D, Shenk TE (2010) Experimental human cytomegalovirus latency in CD14+ monocytes. Proc Natl Acad Sci U S A 107: 20039-20044.
32. Reeves MB, Compton T (2011) Inhibition of inflammatory interleukin-6 activity via extracellular signalregulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells. J Virol 85: 12750-12758.
33. Sherry MM, Reeves A, Wu JK, Cochran BH (2009) STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells 27: 2383-2392.
34. Slinger E, Maussang D, Schreiber A, Siderius M, Rahbar A, et al. (2010) HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 3: ra58.
35. Soroceanu L, Matlaf L, Bezrookove V, Harkins L, Martinez R, et al. (2011) Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype. Cancer Res 71: 6643-6653.
36. Cobbs C, Khan S, Matlaf L, McAllister S, Zider A, et al. (2014) HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation. Oncotarget 5: 1091-1100.
37. Cobbs CS, Soroceanu L, Denham S, Zhang W, Kraus MH (2008) Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res 68: 724-730.
38. Milne RS, Paterson DA, Booth JC (1998) Human cytomegalovirus glycoprotein H/glycoprotein L complex modulates fusion-from-without. J Gen Virol 79 (Pt 4): 855-865.
39. Yurochko AD, Hwang ES, Rasmussen L, Keay S, Pereira L, et al. (1997) The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol 71: 5051-5059.
40. Meissner CS, Koppen-Rung P, Dittmer A, Lapp S, Bogner E (2011) A "coiled-coil" motif is important for oligomerization and DNA binding properties of human cytomegalovirus protein UL77. PLoS One 6: e25115.
41. Loveland AN, Nguyen NL, Brignole EJ, Gibson W (2007) The amino-conserved domain of human cytomegalovirus UL80a proteins is required for key interactions during early stages of capsid formation and virus production. J Virol 81: 620-628.
42. Isomura H, Stinski MF, Murata T, Yamashita Y, Kanda T, et al. (2011) The human cytomegalovirus gene products essential for late viral gene expression assemble into prereplication complexes before viral DNA replication. J Virol 85: 6629-6644.
43. Qian Z, Leung-Pineda V, Xuan B, Piwnica-Worms H, Yu D (2010) Human cytomegalovirus protein pUL117 targets the mini-chromosome maintenance complex and suppresses cellular DNA synthesis. PLoS Pathog 6: e1000814.